🇺🇸 FDA

Company profile · Sponsor

Helsinn

Helsinn Birex Pharmaceuticals

E43F78F · EMA pharma Dublin, IE
Pipeline
1
Drugs
0
Patents
0

Quick answer

Helsinn (E43F78F) is a pharma company. headquartered in Dublin, IE. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E43F78F
Exchange EMA
Company type pharma
Headquarters Dublin, IE

Pipeline (1)

Search pipeline →

  1. Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetron combination product after a single dose administration to healthy male and female volunteers in an open-label, randomised, single centre, 2-treatment, 4-period, 2 sequence replicative design

    Helsinn

    Healthy volunteers

    phase 1 other active

    1 trial

Frequently asked questions

What is Helsinn?

Helsinn (E43F78F) is a pharma company. headquartered in Dublin, IE. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Helsinn sponsor?

We track 1 ClinicalTrials.gov-linked program for Helsinn, including Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetron combination product after a single dose administration to healthy male and female volunteers in an open-label, randomised, single centre, 2-treatment, 4-period, 2 sequence replicative design. Open each program for phase, modality, NCT IDs, and indication details.

Where does Helsinn company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.